Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a leading player in the medical devices industry with a market capitalization of $22.08 billion, has been navigating a complex landscape of operational ...
Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price objective lifted by research analysts at Stifel Nicolaus from ...
Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report)’s stock price gapped up before the market opened on Thursday after ...
Stifel analysts increased their price target for Zimmer Biomet Holdings Inc (NYSE:ZBH) shares from $130.00 to $138.00, while reiterating a Buy rating on the stock. The firm expressed confidence in the ...
Zimmer Biomet Holdings Inc. closed 17.09% short of its 52-week high of $133.90, which the company reached on March 28th.
and dominance in the medical devices industry. However, Zimmer’s performance has remained grim over the longer term. ZBH has declined 11.2% on a YTD basis and nearly 9% over the past 52 weeks ...
NeuroOne reports Q1 fiscal 2025 revenue of $6.2 million, including $3.0 million from Zimmer Biomet collaboration. NeuroOne Medical Technologies Corporation announced preliminary unaudited revenue ...
including its recently expanded exclusive distribution agreement with Zimmer Biomet, one of the world’s largest medical device manufacturers. The webcast will be accompanied by a presentation and ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Thursday, February 6, 2025 at 8:30 a.m. ET. A news release detailing the ...
Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a leading player in the medical devices industry with a market capitalization of $22.08 billion, has been navigating a complex landscape of operational ...